James P. Kelly
2013 - Vanda Pharmaceuticals
In 2013, James P. Kelly earned a total compensation of $1.1M as Senior Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $157,500 |
|---|---|
| Option Awards | $419,844 |
| Salary | $315,000 |
| Stock Awards | $231,800 |
| Other | $21,234 |
| Total | $1,145,378 |
Kelly received $419.8K in option awards, accounting for 37% of the total pay in 2013.
Kelly also received $157.5K in non-equity incentive plan, $315K in salary, $231.8K in stock awards and $21.2K in other compensation.
Rankings
In 2013, James P. Kelly's compensation ranked 6,021st out of 12,286 executives tracked by ExecPay. In other words, Kelly earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,021 out of 12,286 | 51st |
Division Manufacturing | 2,091 out of 4,612 | 55th |
Major group Chemicals And Allied Products | 612 out of 1,462 | 58th |
Industry group Drugs | 440 out of 1,156 | 62nd |
Industry Pharmaceutical Preparations | 354 out of 890 | 60th |
Source: SEC filing on April 28, 2016.
Kelly's colleagues
We found two more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2013.